ID   TEPC-2027
AC   CVCL_RP66
SY   TEPC 2027; TEPC2027; T2027; T2027tc
DR   Wikidata; Q54972070
RX   PubMed=3726549;
RX   PubMed=9002945;
RX   PubMed=9419351;
RX   PubMed=17764563;
CC   Characteristics: Produces IgG1.
CC   Characteristics: IL6 dependent.
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
RX   PubMed=3726549; DOI=10.1126/science.3726549;
RA   Nordan R.P., Potter M.;
RT   "A macrophage-derived factor required by plasmacytomas for survival
RT   and proliferation in vitro.";
RL   Science 233:566-569(1986).
//
RX   PubMed=9002945; DOI=10.1182/blood.V89.2.435;
RA   Feger F., Dubart-Kupperschmitt A., Lacout C., Dusanter-Fourt I.,
RA   Mayeux P., Vainchenker W., Dumenil D.;
RT   "Ectopic expression of the erythropoietin receptor in a murine
RT   interleukin-6-dependent plasmacytoma cell line (TEPC-2027) confers
RT   proliferative responsiveness to erythropoietin.";
RL   Blood 89:435-445(1997).
//
RX   PubMed=9419351; DOI=10.1073/pnas.95.1.189; PMCID=PMC18171;
RA   Amoroso S.R., Huang N.-H., Roberts A.B., Potter M., Letterio J.J.;
RT   "Consistent loss of functional transforming growth factor beta
RT   receptor expression in murine plasmacytomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:189-194(1998).
//
RX   PubMed=17764563; DOI=10.1186/1471-2164-8-302; PMCID=PMC2040348;
RA   Park E.S., Shaughnessy J.D. Jr., Gupta S., Wang H.-Y., Lee J.-S.,
RA   Woo H.G., Zhan F.-H., Owens J.D. Jr., Potter M., Janz S.,
RA   Mushinski J.F.;
RT   "Gene expression profiling reveals different pathways related to Abl
RT   and other genes that cooperate with c-Myc in a model of plasma cell
RT   neoplasia.";
RL   BMC Genomics 8:302.1-302.16(2007).
//